MARKET

GSK

GSK

GSK PLC
NYSE
50.90
+0.34
+0.66%
Opening 13:17 01/07 EST
OPEN
50.73
PREV CLOSE
50.56
HIGH
51.39
LOW
50.65
VOLUME
2.60M
TURNOVER
--
52 WEEK HIGH
51.46
52 WEEK LOW
30.39
MARKET CAP
103.71B
P/E (TTM)
14.18
1D
5D
1M
3M
1Y
5Y
1D
UBS Sticks to Their Hold Rating for GlaxoSmithKline (GSK)
TipRanks · 9h ago
GSK Advances Targeted Cancer Combo Trial, Keeping Its Oncology Pipeline in Focus
TipRanks · 9h ago
BUZZ-Ionis hits seven-year high after partner GSK reveals promising hepatitis B trial results
Reuters · 10h ago
J.P. Morgan Sticks to Its Sell Rating for GlaxoSmithKline (GSK)
TipRanks · 11h ago
GSK Stock (GSK) Climbs as it Hails Potential $2B Cure for Deadly Hepatitis B Virus
TipRanks · 14h ago
GSK announces EC approval of Shingrix in a prefilled syringe
TipRanks · 14h ago
GSK announces B-Wells trials of bepirovirsen met primary endpoint
TipRanks · 14h ago
GSK: Encouraging Bepirovirsen Data but Narrow Commercial Upside Supports Hold Rating
TipRanks · 14h ago
More
About GSK
GSK plc is a biopharma company. The Company’s segments include Commercial Operations and Research and Development. Its portfolio and pipeline are focused on developing medicines and vaccines in four core therapeutic areas, which are the areas of human health it focuses on to prevent and treat disease: respiratory, immunology and inflammation; oncology; human immunodeficiency virus (HIV), and infectious diseases. Its specialty medicines prevent and treat diseases, from HIV to respiratory diseases, immune-mediated conditions like lupus, and cancer. Its vaccine portfolio includes over 20 vaccines to protect people from diseases and infections throughout their lives. General medicines include inhaled medicines for asthma and COPD to antibiotics. It develops and commercializes preclinical antibody-drug conjugate for Metastatic castration-resistant prostate cancer. Its portfolio also includes Efimosfermin, a fibroblast growth factor 21 (FGF21) analog therapeutic in clinical development.

Webull offers GSK plc (ADR) stock information, including NYSE: GSK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GSK stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GSK stock methods without spending real money on the virtual paper trading platform.